ARTELO BIOSCIENCES INC C/WTS 25/06/2024(TO PUR COM) ARTLW 深 滬
已收盤 06-17 16:00:00 美东时间
0.0056
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.0056
- 總市值 1.87万
- 52周最高 0.1498
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.005
- 委 比 0.00%
- 總股本 334.74万
- 歷史最高 1.25
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.005
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Biodesix (NASDAQ:BDSX) shares increased by 21.6% to $0.52 during Wedne...
09-04 05:06
Artelo Biosciences launches public offering; shares down 10%
Artelo Biosciences (NASDAQ:ARTL) has commenced an underwritten public offering of common stock and/or pre-funded warrants. All securities in the offering will be sold by the company itself. The size, ...
09-04 04:50
Artelo Biosciences Announces Interim Results From Phase 2 CAReS Trial With ART27.13, Peripherally Acting Cannabinoid Receptor Agonist For Treatment Of CACS
Catalyst for Advancing Discussions with Pharmaceutical Companies that have Expressed Interest in ART27.13 for CACSConsistent Improvements in Weight Gain, Lean Body Mass, and Activity were Observed Across Treated Patients
09-03 20:47
Artelo Biosciences Approves Common Stock Increase
An update from Artelo Biosciences ( ($ARTL) ) is now available. On August 28, 2...
08-30 04:58
Artelo Biosciences Secures European Patent For ART27.13 Commercial Formulation, Extending Protection Through 2041; Phase 2 Trial Advances For Cancer-Related Anorexia Treatment
Extends Patent Protection Through December 2041ART27.13 is Currently under Evaluation in a Phase 2 Study for the Treatment of Cancer-Related AnorexiaSOLANA BEACH, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Artelo
08-11 21:17
Artelo Biosciences shares are trading higher after the company received written scientific advice from the UK MHRA affirming the proposed design for its Phase 1 trial of ART12.11.
Artelo Biosciences shares are trading higher after the company received written...
08-01 19:51
Artelo Biosciences Announces At-The-Market Offering Agreement
The latest update is out from Artelo Biosciences ( ($ARTL) ). On July 18, 2025,...
07-19 04:57
Artelo Biosciences Analyst See It As An Emerging Biotech
Artelo gets Buy rating from Boral Capital after positive updates on ART27.13, ART26.12, and preclinical success of its candidate for depression.
07-09 03:06
